Comparison of hematological toxicities between innovator and generic cisplatin formulations in cervical cancer patients treated with concurrent chemoradiotherapy

To compare the incidence and degree of hematological toxicity between innovator and generic cisplatin formulations, decreases in white blood cell (WBC) count (leukopenia) and platelet counts (thrombocytopenia) were retrospectively examined, using the Common Toxicity Criteria for Adverse Events ver....

Descripción completa

Detalles Bibliográficos
Autores principales: Oike, Takahiro, Ohno, Tatsuya, Noda, Shin-ei, Sato, Hiro, Tamaki, Tomoaki, Kiyohara, Hiroki, Ando, Ken, Nakano, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3650746/
https://www.ncbi.nlm.nih.gov/pubmed/23242248
http://dx.doi.org/10.1093/jrr/rrs121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3650746/
https://www.ncbi.nlm.nih.gov/pubmed/23242248
http://dx.doi.org/10.1093/jrr/rrs121

Ejemplares similares